A systematic review: Effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction

European Journal of Heart Failure

Volumn 9, Issue 2, 2007, Pages 129-135

  Abdulla, Jawdat ^a   Barlera, Simona ^b   Latini, Roberto ^b   Kjoller Hansen, Lars ^c   Sogaard, Peter ^a   Christensen, Erik ^d   Kober, Lars ^e   Torp Pedersen, Christian ^d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c ROSKILDE HOSPITAL   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

Angiotensin converting enzyme inhibitor; Diastolic and systolic volume; Ejection fraction; Remodelling

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; PLACEBO; RAMIPRIL;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DRUG EFFECT; ENZYME INHIBITION; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; LONG TERM CARE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; SYSTOLE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; DIASTOLE; HEART VENTRICLES; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33847780362     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.05.002     Document Type: Review

References (31)

1. Pfeffer J.M., Pfeffer M.A., and Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57 1 (1985) 84-95
2. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., et al. Myocardial infarct size and ventricular function in rats. Circ Res 44 4 (1979) 503-512
3. Pfeffer M.A., Lamas G.A., Vaughan D.E., Parisi A.F., and Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319 (1988) 80-86
4. Sharpe N., Murphy J., Smith H., and Hannan S. Treatment of patients with symptomless dysfunction after myocardial infarction. Lancet i (1988) 255-259
5. St John Sutton M., Pfeffer M.A., Moye L., et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 96 10 (1997) 3294-3299
6. Pfeffer M.A., Lamas G.A., Vaughan D.E., Parisi A.F., and Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319 2 (1988) 80-86
7. Greenberg B., Quinones M.A., Koilpillai C., et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 91 10 (1995) 2573-2581
8. Nicolosi G.L., Latini R., Marino P., et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Eur Heart J 17 11 (1996) 1646-1656
9. de Kam P.J., Voors A.A., van den Berg M.P., et al. Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol 36 7 (2000) 2047-2053
10. Cohn J.N., Ferrari R., and Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35 3 (2000) 569-582
11. Kjoller-Hansen L., Steffensen R., and Grande P. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES). Am Heart J 148 3 (2004) 475-480
12. Effects of enalapril on left ventricular function and exercise performance after a first acute myocardial infarction. The EDEN Study Investigators. Int J Cardiol 59 3 (1997) 257-265
13. Sogaard P., Gotzsche C.O., Ravkilde J., and Thygesen K. Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation 87 4 (1993) 1093-1099
14. Kjoller-Hansen L., Steffensen R., and Grande P. Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure. J Am Coll Cardiol 37 5 (2001) 1214-1220
15. van Gilst W.H., Kingma J.H., Peels K.H., Dambrink J.H., and St John Sutton M. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol 28 1 (1996) 114-121
16. Borghi C., Marino P., Zardini P., Magnani B., Collatina S., and Ambrosioni E. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. Am Heart J 136 2 (1998) 213-225
17. Oldroyd K.G., Pye M.P., Ray S.G., et al. Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol 68 8 (1991) 713-718
18. Keren G., Pardes A., Eschar Y., et al. One-year clinical and echocardiographic follow-up of patients with congestive cardiomyopathy treated with captopril compared to placebo. Isr J Med Sci 30 1 (1994) 90-98
19. Bonarjee V.V., Carstensen S., Caidahl K., Nilsen D.W., Edner M., and Berning J. Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy. CONSENSUS II Multi-Echo Study Group. Am J Cardiol 72 14 (1993) 1004-1009
20. Sharpe N., Murphy J., Smith H., and Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1 8580 (1988) 255-259
21. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., and Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet 337 8746 (1991) 872-876
22. Kongstad-Rasmussen O., Blomstrand P., Broqvist M., Dahlstrom U., and Wranne B. Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarction. Clin Cardiol 21 11 (1998) 807-811
23. St John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89 1 (1994) 68-75
24. Ambrosioni E., Borghi C., and Magnani B. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party. Am J Cardiol 68 14 (1991) 101D-110D
25. Lonn E., Shaikholeslami R., Yi Q., et al. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction; A substudy of the Heart Outcomes Prevention Evaluation (HOPE) trial. J Am Coll Cardiol 43 12 (2004) 2200-2206
26. Shen W., Li M., Hu H., Zhang X., and Gong L. Cardiac protection by long-term treatment with captopril in patients with acute myocardial infarction. Chin Med J (Engl) 111 2 (1998) 139-141
27. Flather M.D., Yusuf S., Kober L., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 355 9215 (2000) 1575-1581
28. Abdulla J., Abildstrom S.Z., Christensen E., Kober L., and Torp-Pedersen C. A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction. Eur J Heart Fail 6 7 (2004) 927-935
29. Whitehead A. Meta-analysis of controlled clinical trials. John Wiley and Sons Ltd. The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ, England (2002)
30. Baur L.H., Schipperheyn J.J., van der Wall E.E., et al. Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction. Eur Heart J 18 8 (1997) 1313-1321
31. Ray S.G., Pye M., Oldroyd K.G., et al. Early treatment with captopril after acute myocardial infarction. Br Heart J 69 3 (1993) 215-222